✦ LIBER ✦

Interstitial lung disease in infancy

✍ Scribed by S. Balasubramanian; Lalitha Janakiraman; R. Ganesh; M. Deenadayalan; Radhika K. Naidu

Book ID: 107598068
Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 71 KB
Volume: 74
Category: Article
ISSN: 0019-5456
DOI: 10.1007/s12098-007-0113-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interstitial Lung Disease in Systemic Sc

Interstitial Lung Disease in Systemic Sclerosis

✍ Predrag Ostojic; Marco Matucci Cerinic; Richard Silver; Kristin Highland; Nemanj 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 193 KB

Interstitial lung disease in systemic sc

Interstitial lung disease in systemic sclerosis

✍ O. Kaloudi; I. Miniati; S. Alari; M. Matucci-Cerinic 📂 Article 📅 2007 🏛 Springer Milan 🌐 English ⚖ 76 KB

Pulmonary hypertension in interstitial l

Pulmonary hypertension in interstitial lung disease

✍ S. D. Nathan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB

Interstitial Lung Disease in Rheumatoid

Interstitial Lung Disease in Rheumatoid Arthritis

✍ Dana P. Ascherman 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 277 KB

Diagnosis of interstitial lung disease

✍ Andrew Bush 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 252 KB 👁 1 views

Rituximab-induced interstitial lung dise

Rituximab-induced interstitial lung disease

✍ Stephanie A. Wagner; Apurva C. Mehta; Damian A. Laber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract The aim of this study is to characterize rituximab‐induced interstitial lung disease (R‐ILD). The information on all reported cases of R‐ILD was reviewed. This analysis focused on patient characteristics, underlying disease, rituximab dosing schedule, and R‐ILD characteristic‐like sympt